NeuroStar® is now FDA-cleared as a first-line, add-on therapy for adolescent
depression in ages 15 and older!
NeuroStar® is now
FDA-cleared as a
first-line, add-on therapy for adolescent depression in ages 15 and older!
AS SEEN ON TV
NeuroStar TMS is a non-drug treatment for adults with depression, depression with anxiety, and OCD as an add-on therapy.
1st TMS device
FDA-cleared in the United States &
only device
cleared to treat
adolescents.
World’s largest
outcomes registry
for Major
Depressive
Disorder.
One coil,
multiple treatments, no added cost or upgrades necessary.
The only
TMS company
that offers in-practice,
lifetime support.
Only NeuroStar offers TrakStar, a proprietary, HIPAA-compliant patient data management system designed to increase your productivity by identifying patients within your practice who are eligible for AND interested in NeuroStar.
STRENGTHEN TMS AWARENESS
with practice support programs
NeuroStar’s network of “Better Me Providers” is a group of practices committed to meeting the following patient care and responsiveness standards, developed in collaboration with medical experts: performing TMS therapy exclusively with NeuroStar, attending NeuroStar University; ensuring prompt response times by a dedicated NeuroStar coordinator; advising patients about the benefits of a full course of NeuroStar treatment; and optimizing websites and social media content to educate patients.*
NeuroStar University helps optimize your NeuroStar practice through an experiential training course, where you will learn clinical best practices, master TrakStar, and discover how to build NeuroStar awareness to help improve patient access to care.
Co-Op Program
Brand Awareness
Supports your practice by reaching more patients through our Co-Op program, including customized social media and email templates. NeuroStar’s Co-Op Marketing program is unlike anything else in TMS, taking your NeuroStar marketing to the next level.
Your NeuroStar Representative:
ALEXANDER
KILE
- Senior Area Sales Manager based in Tampa, Florida specializing in TMS technology and medical devices
- In 2023, helped 9 NeuroStar practices by adding additional systems to their practices, supporting growth and patient outcomes
- Expertise in Market Planning, Sales, and Business Expansion
- Proven success with private practices, hospitals, VA facilities, and military bases
- Dedicated to supporting NeuroStar providers with nearly 24/7 assistance and focused on expanding access to TMS treatment
What our customers say:
"NeuroStar has the data to support their benefits.They offer hands-on training and customer service, and they have provided ongoing support for our practice. Patient response rates to NeuroStar have been exceptional.”
Dr. Melissa Fickey
Embracing Life Wellness Center
Adult Indications for Use
The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.
The NeuroStar Advanced Therapy System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).
Adolescent Indications for Use
NeuroStar Advanced Therapy is indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (15-21).
Important Safety Information
NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary.
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient).
Visit neurostar.com for full safety and prescribing information.
53-55311-000 Rev A